The Europe sarcopenia treatment market was valued at US$ 993.46 million in 2022 and is expected to reach US$ 1,467.81 million by 2030; it is estimated to register a CAGR of 5.0% from 2022 to 2030.
Rise in Malnutrition and Vitamin Deficiency Among Adults Boosts Europe Sarcopenia Treatment Market
Malnutrition is one of the major risk factors for sarcopenia. According to the WHO, approximately 2.3 billion adults worldwide were undernourished as of 2021, representing nearly 30% of the global population. Among the reported risk factors, protein-energy deficiency is a frequent cause of sarcopenia. Further, vitamin D deficiency or insufficiency is positively associated with an increased risk of multiple illnesses, such as cancer, obesity, cardiovascular disease, and sarcopenia. According to the National Institutes of Health (NIH), nearly 50% of the world's population suffers from vitamin D insufficiency, and ~1 billion people are vitamin D deficient.
Europe Sarcopenia Treatment Market Overview
The sarcopenia treatment market in Europe is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global sarcopenia treatment market and is estimated to register a notable CAGR during the forecast period.
Germany is an attractive market due to its innovative approach toward healthcare. According to the Federal Statistical Office, health expenditure in this country amounted to US$ 474 billion in 2021. The awareness of sarcopenia and sarcopenic obesity (SO) is gradually increasing in aging societies across Germany. Sarcopenia and SO are comparatively uncommon (<5%) among German men aged 70 and above. Therefore, an upsurge in the cases of orthopedic disorders, coupled with the rising demand for nutritional supplements, drives the growth of the sarcopenia treatment market in Germany.
Europe Sarcopenia Treatment Market Revenue and Forecast to 2030 (US$ Million)
Europe Segmentation
The Europe sarcopenia treatment market is categorized into treatment type, distribution channel, and country.
Based on treatment type, the Europe is segmented into vitamin D and calcium supplement, protein supplement, vitamin B12 supplement, and others. The vitamin D and calcium supplement segment held the largest Europe share in 2022.
In terms of distribution channel, the Europe is segmented into pharmacies, retail channels, online channels, and others. The pharmacies segment held the largest Europe share in 2022.
By country, the Europe is segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. Germany dominated the Europe share in 2022.
Abbott Laboratories, Amway Corp, Bayer AG, GSK Plc, Metagenics LLC, Nestle Health Science SA, Novartis AG, Pfizer Inc, and Sanofi SA are some of the leading companies operating in the Europe .
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 993.46 Million |
| Market Size by 2030 | US$ 1,467.81 Million |
| CAGR (2022 - 2030) | 5.0% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By Treatment Type
|
| Regions and Countries Covered |
Europe
|
| Market leaders and key company profiles |
|
1. Abbott Laboratories
2. Amway Corp
3. Bayer AG
4. GSK Plc
5. Metagenics LLC
6. Nestle Health Science SA
7. Novartis AG
8. Pfizer Inc
9. Sanofi SA
The Europe Sarcopenia Treatment Market is valued at US$ 993.46 Million in 2022, it is projected to reach US$ 1,467.81 Million by 2030.
As per our report Europe Sarcopenia Treatment Market, the market size is valued at US$ 993.46 Million in 2022, projecting it to reach US$ 1,467.81 Million by 2030. This translates to a CAGR of approximately 5.0% during the forecast period.
The Europe Sarcopenia Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Sarcopenia Treatment Market report:
The Europe Sarcopenia Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Sarcopenia Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Sarcopenia Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Sarcopenia Treatment Market
